Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta The effect of calcium antagonists
- 31 July 1988
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 72 (2-3), 245-248
- https://doi.org/10.1016/0021-9150(88)90087-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cellsThe American Journal of Cardiology, 1987
- Antiatherogenic properties of calcium antagonistsThe American Journal of Cardiology, 1987
- “Regression” of atherosclerosis in cell culture: Effects of stable prostacyclin analoguesDrug Development Research, 1986
- Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agentsAtherosclerosis, 1986
- Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.Journal of Clinical Investigation, 1985
- Modification of experimental atherosclerosis by calcium-channel blockersThe American Journal of Cardiology, 1985
- Calcium antagonists as antiatherosclerotic drugsDrug Development Research, 1985
- PROSTACYCLIN ANALOGUES AS ANTIATHEROSCLEROTIC DRUGSThe Lancet, 1983
- Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells.Journal of Clinical Investigation, 1982
- Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.Journal of Clinical Investigation, 1981